Reuters logo
BRIEF-Invitae Corp announces a program in partnership with Alnylam Pharmaceuticals
2017年4月3日 / 中午11点41分 / 7 个月前

BRIEF-Invitae Corp announces a program in partnership with Alnylam Pharmaceuticals

April 3 (Reuters) - Alnylam Pharmaceuticals Inc

* Announced a program in partnership with Alnylam Pharmaceuticals to provide genetic testing for hereditary ATTR (HATTR) amyloidosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below